Opko Health Inc header image

Opko Health Inc

OPK

Equity

ISIN null / Valor 3094438

NASDAQ (2026-11-06)
USD 1.73-1.14%

Opko Health Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

OPKO Health Inc is a diversified healthcare company operating in diagnostics, pharmaceuticals, and biotechnology sectors. It owns BioReference Laboratories, one of the largest full-service clinical reference labs in the United States, which serves approximately 11 million patients annually. In the pharmaceutical arena, OPKO develops and markets treatments such as NGENLA™, an FDA-approved human growth hormone therapy available in over 40 markets through a partnership with Pfizer, and RAYALDEE®. The company focuses on advancing multispecific therapies to address serious conditions, including cancers and infectious diseases, supported by a research team with extensive industry experience and collaborations with major organizations like Merck, the National Institutes of Health, and BARDA. Through its integrated operations and strategic partnerships, OPKO Health aims to deliver innovative medical solutions on a global scale.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

25.4%1Y
29.1%3Y
-57.5%5Y

Performance

55.3%1Y
56.6%3Y
60.4%5Y

Volatility

Market cap

1291 M

Market cap (USD)

Daily traded volume (Shares)

6,903,966

Daily traded volume (Shares)

1 day high/low

1.48 / 1.43

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Lupin Limited
Lupin Limited Lupin Limited Valor: 11598960
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.13%INR 1,990.00
ImmunityBio Inc
ImmunityBio Inc ImmunityBio Inc Valor: 110468647
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
7.80%USD 8.63
Astrana Health Inc
Astrana Health Inc Astrana Health Inc Valor: 28041888
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-11.56%USD 34.50
2invest AG
2invest AG 2invest AG Valor: 110098281
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.25%EUR 6.32
Terveystalo Oyj
Terveystalo Oyj Terveystalo Oyj Valor: 37893402
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.81%EUR 6.23
Siemens Healthineers AG
Siemens Healthineers AG Siemens Healthineers AG Valor: 40652181
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.76%EUR 44.66
Beiersdorf AG
Beiersdorf AG Beiersdorf AG Valor: 324660
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.70%EUR 85.26
BridgeBio Pharma Inc
BridgeBio Pharma Inc BridgeBio Pharma Inc Valor: 48204826
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.03%USD 74.29
Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA Fresenius SE & Co. KGaA Valor: 332902
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.18%EUR 52.48
Allogene Therapeutics Inc
Allogene Therapeutics Inc Allogene Therapeutics Inc Valor: 43756548
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.59%USD 1.04